deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT00210626

Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions Anemia
Interventions PROCRIT Placebo
Last updated: Apr 2, 2014 Started: Aug 31, 2005 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

More terminations from Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Other Anemia trials with similar outcome

Browse all Anemia trials

Listed as NCT00210626, this PHASE2 trial focuses on Anemia and remains terminated or withdrawn. Sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., it has been updated 0 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

No change history available.

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
  • Ortho Biotech Products, L.P.
Data source: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Allentown, United States , Baltimore, United States , Birmingham, United States , Cincinnati, United States , Dayton, United States , Denver, United States , El Paso, United States , Gainesville, United States , Hollywood, United States , Indianapolis, United States and 11 more locations